annual EBIT:
$20.84M+$120.79M(+120.85%)Summary
- As of today (July 1, 2025), FOLD annual earnings before interest & taxes is $20.84 million, with the most recent change of +$120.79 million (+120.85%) on December 31, 2024.
- During the last 3 years, FOLD annual EBIT has risen by +$229.93 million (+109.97%).
- FOLD annual EBIT is now at all-time high.
Performance
FOLD EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly EBIT:
-$6.59M-$26.48M(-133.13%)Summary
- As of today (July 1, 2025), FOLD quarterly earnings before interest & taxes is -$6.59 million, with the most recent change of -$26.48 million (-133.13%) on March 31, 2025.
- Over the past year, FOLD quarterly EBIT has increased by +$24.56 million (+78.84%).
- FOLD quarterly EBIT is now -119.92% below its all-time high of $33.08 million, reached on December 31, 2009.
Performance
FOLD quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBIT:
$45.40M+$24.56M(+117.82%)Summary
- As of today (July 1, 2025), FOLD TTM earnings before interest & taxes is $45.40 million, with the most recent change of +$24.56 million (+117.82%) on March 31, 2025.
- Over the past year, FOLD TTM EBIT has increased by +$135.12 million (+150.60%).
- FOLD TTM EBIT is now at all-time high.
Performance
FOLD TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
FOLD EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +120.8% | +78.8% | +150.6% |
| 3 y3 years | +110.0% | +91.0% | +120.1% |
| 5 y5 years | +106.2% | +92.2% | +116.6% |
FOLD EBIT Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +110.0% | -133.1% | +88.8% | at high | +118.9% |
| 5 y | 5-year | at high | +106.2% | -133.1% | +91.0% | at high | +116.6% |
| alltime | all time | at high | +104.8% | -119.9% | +97.6% | at high | +110.3% |
FOLD EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | -$6.59M(-133.1%) | $45.40M(+117.8%) |
| Dec 2024 | $20.84M(-120.9%) | $19.89M(+2.1%) | $20.84M(-216.5%) |
| Sep 2024 | - | $19.48M(+54.3%) | -$17.88M(-63.6%) |
| Jun 2024 | - | $12.62M(-140.5%) | -$49.08M(-45.3%) |
| Mar 2024 | - | -$31.15M(+65.4%) | -$89.72M(-10.2%) |
| Dec 2023 | -$99.95M(-51.2%) | -$18.83M(+60.7%) | -$99.95M(-28.7%) |
| Sep 2023 | - | -$11.72M(-58.2%) | -$140.10M(-5.4%) |
| Jun 2023 | - | -$28.02M(-32.3%) | -$148.03M(-14.4%) |
| Mar 2023 | - | -$41.38M(-29.9%) | -$172.99M(-15.6%) |
| Dec 2022 | -$204.92M(-2.0%) | -$58.98M(+200.3%) | -$204.92M(-6.0%) |
| Sep 2022 | - | -$19.64M(-62.9%) | -$218.07M(-9.4%) |
| Jun 2022 | - | -$52.99M(-27.7%) | -$240.74M(+6.4%) |
| Mar 2022 | - | -$73.30M(+1.6%) | -$226.30M(+8.2%) |
| Dec 2021 | -$209.08M(-17.0%) | -$72.13M(+70.5%) | -$209.08M(+3.4%) |
| Sep 2021 | - | -$42.31M(+9.8%) | -$202.27M(-6.6%) |
| Jun 2021 | - | -$38.55M(-31.3%) | -$216.46M(-3.0%) |
| Mar 2021 | - | -$56.09M(-14.1%) | -$223.06M(-11.4%) |
| Dec 2020 | -$251.83M(-25.3%) | -$65.32M(+15.6%) | -$251.83M(-7.6%) |
| Sep 2020 | - | -$56.50M(+25.1%) | -$272.63M(-0.6%) |
| Jun 2020 | - | -$45.15M(-46.8%) | -$274.16M(-11.0%) |
| Mar 2020 | - | -$84.86M(-1.5%) | -$308.22M(-8.6%) |
| Dec 2019 | -$337.04M(+3.2%) | -$86.12M(+48.4%) | -$337.04M(+5.5%) |
| Sep 2019 | - | -$58.03M(-26.7%) | -$319.35M(-23.2%) |
| Jun 2019 | - | -$79.21M(-30.3%) | -$415.82M(+5.7%) |
| Mar 2019 | - | -$113.68M(+66.1%) | -$393.54M(+20.5%) |
| Dec 2018 | -$326.69M(-24.4%) | -$68.43M(-55.7%) | -$326.69M(+1.0%) |
| Sep 2018 | - | -$154.50M(+171.4%) | -$323.58M(-26.6%) |
| Jun 2018 | - | -$56.93M(+21.6%) | -$441.08M(+3.0%) |
| Mar 2018 | - | -$46.82M(-28.3%) | -$428.06M(-0.9%) |
| Dec 2017 | -$431.88M(+117.7%) | -$65.33M(-76.0%) | -$431.88M(+1.3%) |
| Sep 2017 | - | -$272.00M(+519.5%) | -$426.35M(+113.4%) |
| Jun 2017 | - | -$43.91M(-13.3%) | -$199.74M(-3.2%) |
| Mar 2017 | - | -$50.65M(-15.3%) | -$206.28M(+4.0%) |
| Dec 2016 | -$198.38M(+52.0%) | -$59.80M(+31.7%) | -$198.38M(+9.8%) |
| Sep 2016 | - | -$45.39M(-10.0%) | -$180.63M(+4.4%) |
| Jun 2016 | - | -$50.45M(+18.0%) | -$173.02M(+15.8%) |
| Mar 2016 | - | -$42.75M(+1.7%) | -$149.37M(+14.4%) |
| Dec 2015 | -$130.54M(+90.4%) | -$42.05M(+11.3%) | -$130.54M(+18.2%) |
| Sep 2015 | - | -$37.78M(+41.0%) | -$110.45M(+23.5%) |
| Jun 2015 | - | -$26.80M(+12.0%) | -$89.44M(+16.3%) |
| Mar 2015 | - | -$23.92M(+8.9%) | -$76.88M(+12.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2014 | -$68.56M(+8.6%) | -$21.95M(+30.9%) | -$68.56M(+10.0%) |
| Sep 2014 | - | -$16.77M(+17.8%) | -$62.33M(+3.6%) |
| Jun 2014 | - | -$14.24M(-8.6%) | -$60.14M(-1.8%) |
| Mar 2014 | - | -$15.59M(-0.9%) | -$61.24M(-2.9%) |
| Dec 2013 | -$63.10M(+21.5%) | -$15.73M(+7.9%) | -$63.10M(+4.1%) |
| Sep 2013 | - | -$14.58M(-4.9%) | -$60.62M(-2.7%) |
| Jun 2013 | - | -$15.34M(-12.1%) | -$62.31M(+10.7%) |
| Mar 2013 | - | -$17.45M(+31.7%) | -$56.30M(+8.4%) |
| Dec 2012 | -$51.94M(+8.5%) | -$13.25M(-18.6%) | -$51.94M(+1.9%) |
| Sep 2012 | - | -$16.27M(+74.4%) | -$50.96M(+14.7%) |
| Jun 2012 | - | -$9.33M(-28.8%) | -$44.41M(-6.9%) |
| Mar 2012 | - | -$13.09M(+6.8%) | -$47.69M(-0.4%) |
| Dec 2011 | -$47.89M(-14.2%) | -$12.26M(+26.1%) | -$47.89M(-7.5%) |
| Sep 2011 | - | -$9.73M(-22.8%) | -$51.80M(-9.7%) |
| Jun 2011 | - | -$12.60M(-5.3%) | -$57.36M(+2.4%) |
| Mar 2011 | - | -$13.30M(-17.7%) | -$56.02M(+0.4%) |
| Dec 2010 | -$55.81M(+787.5%) | -$16.17M(+5.7%) | -$55.81M(+750.2%) |
| Sep 2010 | - | -$15.29M(+35.8%) | -$6.57M(+42.1%) |
| Jun 2010 | - | -$11.26M(-14.0%) | -$4.62M(-33.5%) |
| Mar 2010 | - | -$13.09M(-139.6%) | -$6.94M(+10.3%) |
| Dec 2009 | -$6.29M(-83.9%) | $33.08M(-347.9%) | -$6.29M(-87.3%) |
| Sep 2009 | - | -$13.35M(-1.7%) | -$49.43M(+8.9%) |
| Jun 2009 | - | -$13.58M(+9.2%) | -$45.38M(+7.3%) |
| Mar 2009 | - | -$12.44M(+23.7%) | -$42.29M(+8.1%) |
| Dec 2008 | -$39.14M(-14.6%) | -$10.06M(+8.2%) | -$39.14M(-8.0%) |
| Sep 2008 | - | -$9.30M(-11.4%) | -$42.56M(-5.6%) |
| Jun 2008 | - | -$10.49M(+13.0%) | -$45.07M(+0.5%) |
| Mar 2008 | - | -$9.29M(-31.1%) | -$44.86M(-2.1%) |
| Dec 2007 | -$45.80M(-2.2%) | -$13.48M(+14.2%) | -$45.80M(+4.3%) |
| Sep 2007 | - | -$11.81M(+14.8%) | -$43.91M(+0.5%) |
| Jun 2007 | - | -$10.28M(+0.5%) | -$43.69M(-2.9%) |
| Mar 2007 | - | -$10.23M(-11.7%) | -$44.99M(-2.9%) |
| Dec 2006 | -$46.86M(+124.9%) | -$11.59M(+0.0%) | -$46.34M(+16.6%) |
| Sep 2006 | - | -$11.59M(0.0%) | -$39.75M(+19.9%) |
| Jun 2006 | - | -$11.59M(0.0%) | -$33.16M(+24.8%) |
| Mar 2006 | - | -$11.59M(+132.0%) | -$26.57M(+33.0%) |
| Dec 2005 | -$20.83M(+136.5%) | -$4.99M(0.0%) | -$19.97M(+33.3%) |
| Sep 2005 | - | -$4.99M(0.0%) | -$14.98M(+50.0%) |
| Jun 2005 | - | -$4.99M(0.0%) | -$9.99M(+100.0%) |
| Mar 2005 | - | -$4.99M | -$4.99M |
| Dec 2004 | -$8.81M(+33.4%) | - | - |
| Dec 2003 | -$6.60M | - | - |
FAQ
- What is Amicus Therapeutics annual earnings before interest & taxes?
- What is the all time high annual EBIT for Amicus Therapeutics?
- What is Amicus Therapeutics annual EBIT year-on-year change?
- What is Amicus Therapeutics quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Amicus Therapeutics?
- What is Amicus Therapeutics quarterly EBIT year-on-year change?
- What is Amicus Therapeutics TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Amicus Therapeutics?
- What is Amicus Therapeutics TTM EBIT year-on-year change?
What is Amicus Therapeutics annual earnings before interest & taxes?
The current annual EBIT of FOLD is $20.84M
What is the all time high annual EBIT for Amicus Therapeutics?
Amicus Therapeutics all-time high annual earnings before interest & taxes is $20.84M
What is Amicus Therapeutics annual EBIT year-on-year change?
Over the past year, FOLD annual earnings before interest & taxes has changed by +$120.79M (+120.85%)
What is Amicus Therapeutics quarterly earnings before interest & taxes?
The current quarterly EBIT of FOLD is -$6.59M
What is the all time high quarterly EBIT for Amicus Therapeutics?
Amicus Therapeutics all-time high quarterly earnings before interest & taxes is $33.08M
What is Amicus Therapeutics quarterly EBIT year-on-year change?
Over the past year, FOLD quarterly earnings before interest & taxes has changed by +$24.56M (+78.84%)
What is Amicus Therapeutics TTM earnings before interest & taxes?
The current TTM EBIT of FOLD is $45.40M
What is the all time high TTM EBIT for Amicus Therapeutics?
Amicus Therapeutics all-time high TTM earnings before interest & taxes is $45.40M
What is Amicus Therapeutics TTM EBIT year-on-year change?
Over the past year, FOLD TTM earnings before interest & taxes has changed by +$135.12M (+150.60%)